Increased transforming growth factor-β1 gene expression in human liver disease

Giorgio Annoni, Francis R. Weiner, Mark A Zern

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

We recently demonstrated that transforming growth factor-β1 stimulates collagen synthesis in hepatic cells in vitro, and that the synthesis of this cytokine is markedly increased in two rodent models of hepatic fibrosis. In the present study, we investigated the association of transforming growth factor-β1 (TFG-β1) gene expression in human liver disease. Sixteen patients with active liver disease had percutaneous liver biopsies performed for diagnostic purposes. Total RNA was extracted from an unused portion of each biopsy and then subjected to hybridization analysis with the following human cDNA clones: albumin, pro α1 (I) collagen, and TGF-β1. Surgical liver biopsy specimens from two patients without hepatic disease were used as controls. When compared to controls, the patients with active liver disease had a 19% decrease in albumin, a 97% increase in type I collagen, and a 120% increase in transforming growth factor-β1 mRNA levels. Moreover, steady-state levels of TGF-β1 and procollagen mRNAs were significantly correlated. Nuclear run-on assays showed that livers from two patients with fibrosis had TGF-β1 transcription rates that were more than 2-fold higher than rates in control livers. These findings indicate that transforming growth factor-β1 gene expression is significantly enhanced in man during active liver disease.

Original languageEnglish (US)
Pages (from-to)259-264
Number of pages6
JournalJournal of Hepatology
Volume14
Issue number2-3
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Transforming Growth Factors
Liver Diseases
Gene Expression
Liver
Biopsy
Albumins
Fibrosis
Collagen
Procollagen
Messenger RNA
Collagen Type I
Hepatocytes
Rodentia
Complementary DNA
Clone Cells
RNA
Cytokines

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Increased transforming growth factor-β1 gene expression in human liver disease. / Annoni, Giorgio; Weiner, Francis R.; Zern, Mark A.

In: Journal of Hepatology, Vol. 14, No. 2-3, 1992, p. 259-264.

Research output: Contribution to journalArticle

Annoni, Giorgio ; Weiner, Francis R. ; Zern, Mark A. / Increased transforming growth factor-β1 gene expression in human liver disease. In: Journal of Hepatology. 1992 ; Vol. 14, No. 2-3. pp. 259-264.
@article{64c185dca71a46de90698dee1a12cc47,
title = "Increased transforming growth factor-β1 gene expression in human liver disease",
abstract = "We recently demonstrated that transforming growth factor-β1 stimulates collagen synthesis in hepatic cells in vitro, and that the synthesis of this cytokine is markedly increased in two rodent models of hepatic fibrosis. In the present study, we investigated the association of transforming growth factor-β1 (TFG-β1) gene expression in human liver disease. Sixteen patients with active liver disease had percutaneous liver biopsies performed for diagnostic purposes. Total RNA was extracted from an unused portion of each biopsy and then subjected to hybridization analysis with the following human cDNA clones: albumin, pro α1 (I) collagen, and TGF-β1. Surgical liver biopsy specimens from two patients without hepatic disease were used as controls. When compared to controls, the patients with active liver disease had a 19{\%} decrease in albumin, a 97{\%} increase in type I collagen, and a 120{\%} increase in transforming growth factor-β1 mRNA levels. Moreover, steady-state levels of TGF-β1 and procollagen mRNAs were significantly correlated. Nuclear run-on assays showed that livers from two patients with fibrosis had TGF-β1 transcription rates that were more than 2-fold higher than rates in control livers. These findings indicate that transforming growth factor-β1 gene expression is significantly enhanced in man during active liver disease.",
author = "Giorgio Annoni and Weiner, {Francis R.} and Zern, {Mark A}",
year = "1992",
doi = "10.1016/0168-8278(92)90168-O",
language = "English (US)",
volume = "14",
pages = "259--264",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Increased transforming growth factor-β1 gene expression in human liver disease

AU - Annoni, Giorgio

AU - Weiner, Francis R.

AU - Zern, Mark A

PY - 1992

Y1 - 1992

N2 - We recently demonstrated that transforming growth factor-β1 stimulates collagen synthesis in hepatic cells in vitro, and that the synthesis of this cytokine is markedly increased in two rodent models of hepatic fibrosis. In the present study, we investigated the association of transforming growth factor-β1 (TFG-β1) gene expression in human liver disease. Sixteen patients with active liver disease had percutaneous liver biopsies performed for diagnostic purposes. Total RNA was extracted from an unused portion of each biopsy and then subjected to hybridization analysis with the following human cDNA clones: albumin, pro α1 (I) collagen, and TGF-β1. Surgical liver biopsy specimens from two patients without hepatic disease were used as controls. When compared to controls, the patients with active liver disease had a 19% decrease in albumin, a 97% increase in type I collagen, and a 120% increase in transforming growth factor-β1 mRNA levels. Moreover, steady-state levels of TGF-β1 and procollagen mRNAs were significantly correlated. Nuclear run-on assays showed that livers from two patients with fibrosis had TGF-β1 transcription rates that were more than 2-fold higher than rates in control livers. These findings indicate that transforming growth factor-β1 gene expression is significantly enhanced in man during active liver disease.

AB - We recently demonstrated that transforming growth factor-β1 stimulates collagen synthesis in hepatic cells in vitro, and that the synthesis of this cytokine is markedly increased in two rodent models of hepatic fibrosis. In the present study, we investigated the association of transforming growth factor-β1 (TFG-β1) gene expression in human liver disease. Sixteen patients with active liver disease had percutaneous liver biopsies performed for diagnostic purposes. Total RNA was extracted from an unused portion of each biopsy and then subjected to hybridization analysis with the following human cDNA clones: albumin, pro α1 (I) collagen, and TGF-β1. Surgical liver biopsy specimens from two patients without hepatic disease were used as controls. When compared to controls, the patients with active liver disease had a 19% decrease in albumin, a 97% increase in type I collagen, and a 120% increase in transforming growth factor-β1 mRNA levels. Moreover, steady-state levels of TGF-β1 and procollagen mRNAs were significantly correlated. Nuclear run-on assays showed that livers from two patients with fibrosis had TGF-β1 transcription rates that were more than 2-fold higher than rates in control livers. These findings indicate that transforming growth factor-β1 gene expression is significantly enhanced in man during active liver disease.

UR - http://www.scopus.com/inward/record.url?scp=0026600495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026600495&partnerID=8YFLogxK

U2 - 10.1016/0168-8278(92)90168-O

DO - 10.1016/0168-8278(92)90168-O

M3 - Article

VL - 14

SP - 259

EP - 264

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 2-3

ER -